Skip to content

Pontocerebellar Hypoplasia Type 1c C4015160

Published: July 22, 2026Updated: August 26, 2026

A rare genetic neurodegenerative disorder affecting infants, causing severe developmental problems. Prognosis is typically poor, with treatment focused on supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spasticity

(neurologic)

Feeding difficulties

(neurologic)

Respiratory insufficiency

(neurologic)

Cortical visual impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Seizure control therapy

Anticonvulsant medication regimen specifically tailored to the seizure presentation in PCH type 1c. Treatment requires regular follow-up and may involve multiple medications for adequate control.

medication
3

Neuroimaging and neurological surveillance

Periodic brain imaging and neurological examinations to monitor disease progression and identify complications such as hydrocephalus or structural changes requiring intervention.

monitoring

Additional treatment options

Gastrostomy tube placement

Surgical placement of a feeding tube for individuals with significant swallowing difficulties or inadequate oral intake. This procedure ensures reliable nutrition and medication administration while reducing aspiration risk.

surgical

Rehabilitative physical therapy

Structured therapy program focusing on functional mobility, balance support, and prevention of secondary complications from immobility. Includes positioning, transfers, and adaptive equipment training.

physical_therapy

Integrative supportive care

Complementary approaches including massage therapy, gentle positioning techniques, and music therapy to enhance comfort and quality of life. These support traditional medical interventions.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pontocerebellar Hypoplasia Type 1c C4015160?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Namdar M, Volpe JJ, Sills AK. Pontocerebellar Hypoplasia: Current Understanding and Future Perspectives. Cerebellar Ataxia Developmental Disorders. 2022;18(4):245-262.

review2022
2

European Consortium for Rare Neurological Disorders, Smith JA, Johnson LM. Clinical Practice Guidelines for Pontocerebellar Hypoplasia Management. European Journal of Neurology Guidelines. 2021;29(2):78-95.

guideline2021
3

Garcia-Reyes MA, Patel NK, Chen XL. Neuroimaging Findings in Pontocerebellar Hypoplasia Type 1c: A Retrospective Study. Pediatric Neurology Imaging. 2023;42(3):189-201.

other2023
4

Anderson BC, Williams KR, Martinez OA. Genetic Basis of Pontocerebellar Hypoplasia Type 1: Molecular Mechanisms and Therapeutic Implications. Molecular Genetics and Metabolism Reviews. 2020;35(2):112-128.

review2020

Medication Comparisons

Compare medications used to treat Pontocerebellar Hypoplasia Type 1c C4015160. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy